← 홈

ADC

1,068개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,068개
ADCBiologicstaleHoffmann-La RochePhase 2

ZN-A-1041 (ZN-A-1041)

Advanced Solid Tumors; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 5상태 RECRUITING
ADCBiologicstaleSeagen Inc.Phase 2

ladiratuzumab vedotin (ladiratuzumab vedotin)

HER2 Positive Breast Neoplasms; Hormone Receptor Positive Breast Neoplasms · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 34%임상시험 5상태 ACTIVE
ADCBiologicstaleSeagen, a wholly owned subsidia…Phase 1

sigvotatug vedotin (sigvotatug vedotin)

Carcinoma, Non-Small Cell Lung; Squamous Cell Carcinoma of Head and Neck · Carcinoma, Non-Small Cell Lung

#CarcinomaNon-SmallCellLung#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
임상시험 5상태 RECRUITING
ADCBiologicstaleRemeGen Co., Ltd.Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, 12 cycle RC48 and JS001)

Urology · Urology

#Urology#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleTelix Pharmaceuticals (Innovati…Phase 1

177Lu-DOTA-TLX591 (177Lu-DOTA-TLX591)

Metastatic Prostate Cancer · Metastatic Prostate Cancer

#MetastaticProstateCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 ACTIVE
ADCBiologicstaleTelix Pharmaceuticals (Innovati…Phase 3

177Lu-TLX591 (177Lu-TLX591)

Metastatic Castration-resistant Prostate Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

5-hydroxytryptamine subtype 3 receptor antagonist (5-hydroxytryptamine subtype 3 receptor antagonist)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 4상태 RECRUITING
ADCBiologicstaleArtiva Biotherapeutics, Inc.Phase 2

AB-201 (AB-201)

Breast Cancer; Gastric Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 4상태 DISCONTINUED
ADCBiologicstaleMultitude Therapeutics Inc.Phase 2

AMT-116 (AMT-116)

Advanced Non-small Cell Lung Cancer (NSCLC) · Advanced Non-small Cell Lung Cancer (NSC

#AdvancedNon-smallCellLungCancerN#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Amcenestrant + Letrozole (Amcenestrant + Letrozole)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 42.3%임상시험 4상태 RECRUITING
ADCBiologicstaleBioNTech SEPhase 3

BNT324 (BNT324)

Advanced Lung Cancer · Metastatic Castration-resistant Prostate

#MetastaticCastration-resistantPr#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 4상태 RECRUITING
ADCBiologicstaleHoffmann-La RochePhase 2

Belvarafenib (Belvarafenib)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleDay One Biopharmaceuticals, Inc.Phase 1

DAY301 (DAY301)

Advanced or Metastatic Solid Tumors · Advanced or Metastatic Solid Tumors

#AdvancedorMetastaticSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleDualityBio Inc.Phase 2

DB-1311/BNT324 (DB-1311/BNT324)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleFBD Biologics LimitedPhase 2

HCB101 (HCB101)

Solid Cancer · Solid Cancer

#SolidCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleAbbViePhase 2

IMGN632 (IMGN632)

Blastic Plasmacytoid Dendritic Cell Neoplasm; Myeloproliferative Neoplasm · Blastic Plasmacytoid Dendritic Cell Neop

#BlasticPlasmacytoidDendriticCell#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 4상태 RECRUITING
ADCBiologicstaleMerck Healthcare KGaA, Darmstad…Phase 1

M9140 (M9140)

Solid Tumors; Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 4상태 RECRUITING
ADCBiologicstaleMinghui Pharmaceutical (Hangzho…Phase 2

MHB036C (MHB036C)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

MK-3120 (MK-3120)

Bladder Cancer · Bladder Cancer

#BladderCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 4상태 RECRUITING
ADCBiologicstaleMillennium Pharmaceuticals, Inc.Phase 1

MLN0264 (MLN0264)

Advanced Gastrointestinal Malignancies · Advanced Gastrointestinal Malignancies

#AdvancedGastrointestinalMalignan#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 0%임상시험 4상태 ACTIVE

28 / 54 페이지

← 이전다음 →